HYDERABAD: Dr Reddy s Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import Sputnik vaccine into India for restricted use in emergency situations.
The permission is subject to provisions of New Drug and Clincial Trials Rules 2019 under the Drugs and Cosmetics Act.
In September last year, Dr Reddy s had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India.
In addition to trials conducted in Russia by RDIF. Phase two and three clinical trials of the vaccine were carried out by Dr Reddy s in India.
India News: NEW DELHI: A day after EC banned Mamata from campaigning for 24 hours, the poll body on Tuesday served a notice to BJP president Dilip Ghosh for sugge.
NEW DELHI: Sushil Chandra assumed charge as the 24th chief election commissioner on Tuesday.
Chandra was appointed as the CEC on Monday, the day Sunil Arora demitted office.
Chandra was appointed as an election commissioner on February 14, 2019, ahead of the Lok Sabha elections. He would demit office on May 14, 2022.
Under him, the Election Commission (EC) will hold assembly polls in Goa, Manipur, Uttarakhand, Punjab and Uttar Pradesh.
The term of the assemblies of Goa, Manipur, Uttarakhand and Punjab ends on various dates in March next year.
The term of the Uttar Pradesh assembly ends on May 14 next year.
Chandra belongs to the 1980 batch of the Indian Revenue Service.
NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained.
As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management.
How did Remdesivir come into use?
Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease.
India News: NEW DELHI: The Centre on Tuesday noted that India is well past last year's highest Covid surge and the continuous increase in daily cases is a matter .